Literature DB >> 2182919

Chronic cor pulmonale. Etiology and management.

H I Palevsky1, A P Fishman.   

Abstract

Cor pulmonale is right ventricular enlargement secondary to pulmonary hypertension. Although most often caused by parenchymal lung disease, derangements of the ventilatory drive, the respiratory pumping mechanism, or the pulmonary vascular bed may also result in right ventricular hypertrophy and dilatation. Arterial hypoxemia (and resultant polycythemia), hypercapnia, and respiratory acidosis all contribute to the increased afterload on the right ventricle. Diagnosis is often difficult, since pulmonary vascular disease, pulmonary hypertension, and cor pulmonale have few specific manifestations, especially early in their evolution. Treatment is primarily directed at the underlying pulmonary or ventilatory disorder, rather than at the right ventricular failure per se. Supplemental oxygen is essential to avoid hypoxia; corticosteroids, anticoagulants, vasodilators, and other specific therapies are used as indicated to treat the underlying pulmonary disorders. When medical therapies fail, lung or heart-lung transplantation has become a possibility for selected patients.

Entities:  

Mesh:

Year:  1990        PMID: 2182919

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Cor Pulmonale.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

2.  Sildenafil--a possible treatment for acute pulmonary hypertension during cardiac surgery.

Authors:  Wendy Wheeler; Shelly Hayes; Ngo Nguyen; Anthony M Cilla; Joseph Rybowicz; Comeco C Jones; Michael A E Ramsay; Shelley A Hall; Dan Meyer; John Capehart; Michael E Jessen; Steves Ring
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-01

Review 3.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 4.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 5.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

6.  Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.

Authors:  Sat Sharma; Tarek Kashour; Roger Philipp
Journal:  Tex Heart Inst J       Date:  2005

7.  Cor pulmonale and silicosis: a necropsy based case-control study.

Authors:  J Murray; G Reid; D Kielkowski; M de Beer
Journal:  Br J Ind Med       Date:  1993-06

Review 8.  Treatment of pulmonary hypertension.

Authors:  Rajendrakumar Patel; Wilbert S Aronow; Laxeshkumar Patel; Kaushang Gandhi; Harit Desai; Dhiraj Kaul; Sumir P Sahgal
Journal:  Med Sci Monit       Date:  2012-04

9.  Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Substudy.

Authors:  Ozair Rahman; Michael Markl; Pallavi Balte; Haben Berhane; Carmen Blanken; Kenichiro Suwa; Stephen Dashnaw; Oliver Wieben; David A Bluemke; Martin R Prince; Joao Lima; Erin Michos; Bharath Ambale-Venkatesh; Eric A Hoffman; Antoinette S Gomes; Karol Watson; Yanping Sun; James Carr; R Graham Barr
Journal:  Radiology       Date:  2019-07-23       Impact factor: 29.146

10.  Correlation between the Pulmonary Artery Pressure Measured in Echocardiography and Pulmonary Artery Diameter in the CT-Scan of Patients Suffering from Interstitial Lung Disease.

Authors:  Atefeh Fakharian; Nima Hamidi; Behnam Haji Hosseinloo; Samira Rezaei; Elnaz Ehteshami Afshar; Babak Sharif-Kashani; Neda Behzadnia; Mehrdad Bakhshayesh Karam; Latif Gachkar; Habib Emami
Journal:  Tanaffos       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.